A Single and Multiple Ascending Dose Study of Subcutaneously Administered JNJ-75220795

Clinical trial NCT04844450 · COMPLETED

Trial details

NCT number: NCT04844450
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Fatty Liver Disease

Start date: 2021-04-29
Primary completion: 2023-03-31
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.